New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
14:27 EDTOSUROraSure decline creates long-term buying opportunity, says Barrington
After OraSure reported weaker than expected Q3 results and provided weaker than expected Q4 guidance, Barrington expects the company to start rapidly penetrating the HCV and HIV markets. The firm maintains a $12.50 target and Outperform rating.
News For OSUR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
10:14 EDTOSURHigh option volume stocks
Subscribe for More Information
09:38 EDTOSURCLDF teams with Walgreens to offer OraSure HCV test for free
The Chronic Liver Disease Foundation announced earlier that it's collaborating with Walgreens (WBA) to offer free hepatitis C testing with the OraQuick HCV Rapid Test at more than 60 Walgreens retail pharmacies in 12 cities throughout the country. The program, which is slated to launch this August and run through January 2016, will offer free rapid HCV testing on specific days and times each week to patients at risk for HCV. The test is made by OraSure (OSUR).
May 18, 2015
07:22 EDTOSURUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use